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The gene expression of human embryonic stem cells (hESC) is a critical aspect for understanding
the normal and pathological development of human cells and tissues. Current bulk gene
expression assays rely on RNA extracted from cell and tissue samples with various degree of
cellular heterogeneity. These ‘cell population averaging’ data are difficult to interpret, especially
for the purpose of understanding the regulatory relationship of genes in the earliest phases of
development and differentiation of individual cells. Here, we report a microfluidic approach that
can extract total mRNA from individual single-cells and synthesize cDNA on the same device
with high mRNA-to-cDNA efficiency. This feature makes large-scale single-cell gene expression
profiling possible. Using this microfluidic device, we measured the absolute numbers of mRNA
molecules of three genes (B2M, Nodal and Fzd4) in a single hECS. Our results indicate that gene
expression data measured from cDNA of a cell population is not a good representation of the
expression levels in individual single cells. Within the G0/G1 phase pluripotent hESC population,
some individual cells did not express all of the 3 interrogated genes in detectable levels.
Consequently, the relative expression levels, which are broadly used in gene expression studies, are
very different between measurements from population cDNA and single-cell cDNA. The results
underscore the importance of discrete single-cell analysis, and the advantages of a microfluidic
approach in stem cell gene expression studies.
Introduction
The fundamental challenge for stem cell gene expression
studies is that stem cells are extremely rare in the context of
numerous differentiated and mature cells, and there is no
definitive marker for the isolation of a homogenous pure stem
cell population. There is especially a lack of markers to
distinguish closely related stem cells and progenitor cells.
Many stem cell gene expression profiling studies have by
default used the heterogeneous populations of stem cells and
progenitor cells. Data obtained from these population-
averaging expression profiles reflect the sum of all the sub-
populations, the population-averaging expression. Without
knowing the relative percentages of stem cells and progenitor
cells in the interrogated population, these gene expressions
profiles, which are the sum of all expression profiles from
various cell types, are very difficult to interpret and not
sufficiently informative. Even if the percentages are known,
variation in the expression profiles among individual stem cells
in different phases of the cell cycle would not be detectable by
these current methods. Single-cell transcriptome analysis can
overcome this hurdle and provide precise information of
stem cell gene regulation as revealed in individual separately
analyzed cells.
Single-cell gene expression profiling from early embryos has
suggested the transient expression of critical regulatory genes,
again underscoring the importance of systematical single-cell
expression profiling.1,2 Currently, multiple color fluorescent-
activated cell sorting (FACS) has a limited utility for isolation
of pure stem cell populations due to a lack of discriminating
cell markers. Single-cell gene expression profiling studies with
laser capture microdissection (LCM),3–12 patch-clamp analy-
sis,2,13,14 as well as in situ mRNA amplification13,15 have been
reported, but analysis of a large number of cells has proven to
be very difficult with these methods. Single-cell whole genome
microarray gene expression screening4,5,16 and single-cell
cDNA library construction1,17,18 also have been conducted
on a limited number of cells. While these studies demonstrate
the potential value of single-cell gene expression profiling, they
also showed the limitation of these methods in processing a
large number of samples. Material loss and low biochemical
reaction efficiency (mRNA capture and RT reaction) are other
major challenges for single-cell analysis. A single mammalian
cell contains 20–40 pg of total RNA,19,20 but only 0.5–1.0 pg of
mRNA (105 to106 mRNA molecules).21 Therefore, detecting
single-cell mRNA is difficult with current methods.
The microfluidic device described here significantly increases
the mRNA-to–cDNA processing efficiency y5 fold to 54%
compared to bulk reactions (y12%).22,23 With this device,
we measured the absolute copy number of three genes in
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individual single hESCs and compared these data to those
obtained from the cDNA of FACS sorted hESCs in the G0/G1
phase. Our results indicate that the hESC colony is a
heterogeneous cell population and many single cells do not
express all three of the interrogated genes. This result suggests
that pluripotent hESC colonies are not homogeneous cell
populations, rather they are highly heterogeneous cell popula-
tions regulated by different gene networks. Besides stochastic
factors of individual cells, heterogeneity of cells with respect to
cell cycle and other factors may be a major contributor to
observed variations in mammalian single-cell gene expression.
Materials and methods
Mold fabrication
All photomasks were designed with AutoCAD software, and
printed at a resolution of 20 000 dots per inch on transparency
films (CAD/Art services). We used both the control mold and
flow mold to define device features. The control mold with
24 mm high features was fabricated with a single step using
SU8-2025 (Microchem, USA). The flow mold was fabricated
with three lithographic steps. First we defined the 10 mm high
column construction flow channels with SU8-2010 (Microchem,
USA). Then the 12 mm high output, bead and buffer delivery
channels were fabricated using SPR220-7 (Shipley, USA). In
addition, a hard bake process at 200 uC facilitating channel
rounding was necessary for valve closure. The last step was to
construct the 40 mm high cell loading channels with AZ-50
(Clariant). In all optical lithography processes, mold exposures
were under UV light on a MJB mask aligner (7 mW cm22).
Device fabrication
The microfluidic devices were fabricated by multilayer soft
lithography with the silicone elastomer polydimethylsiloxane
(PDMS, RTV615, General Electric, USA). Each device
employs push-up valve geometry and consists of a three layer
elastomeric structure.
The molds were first exposed to chlorotrimethylsilane
(TMCS, Aldrich) vapor for 2 min to promote elastomer
release after the baking steps. For the flow layer of the device,
a mixture of PDMS (5 parts RTV615A : 1 part RTV615B) was
poured onto the flow mold. After degassing, the flow molds
were baked for 45 min at 80 uC. For the control layer of the
device, a mixture of PDMS (20 parts RTV615A : 1 part
RTV615B) was spun on the control mold at 1800 rpm and
baked for 30 min at 80 uC. The flow layer was separated from
the flow mold and flow channel access holes were then punched.
Next, the flow and control layers were aligned and baked for
45 min at 80 uC. The two layer structure was peeled from the
control mold with control channel access holes punched, and
was mounted to another thin PDMS layer made by spinning
20 : 1 PDMS mixture on a blank wafer. After baking for 3 hours
at 80 uC, the three layer structure was bonded to a clean
microscope slide and baked overnight at 80 uC.
Microfluidic station
Fig. 1 shows the setting of the microfluidic system and the
hESC colonies for microfluidic analysis. The microfluidic
valves within the device are controlled by individual pressure
regulators (Fluidigm, USA) and are interfaced via 23 gauge
stainless steel tubing (New England Small Tube) and tygon
tubing (VWR). An NI-DAQ card through a Labview interface
(National Instruments) was used to control the pressure
regulators.
hESC culture
The hESC line (H9) was obtained from the WiCell Research
Institute (Madison, WI) and maintained as instructed.24
Undifferentiated hESCs were cultured on an irradiated
(5500 rads) layer of mouse embryonic fibroblast (MEF)
feeder cells in 6-well plates or in matrigel-coated plates with
MEF conditioned medium. To avoid contamination of mouse
cells from the MEF, hESC colonies were dissected and
transferred to matrigel-coated plates before using for micro-
fluidic processing.
MEF were prepared from the embryos of 13–14 day
pregnant CF-1 mice (Charles River Labs) and stocks were
cryopreserved until required for culture of hESCs. hESCs were
consistently observed as large clumps that appeared on the
matrigel-coated surface, consistent with the published observa-
tions of others. Periodic karyotyping confirmed their human
diploid chromosomal character. After injection into severe
combined immunodeficient (SCID) mice, these cells produced
teratomas which include tissues of ectodermal, mesodermal
and endodermal origin. Immunostaining of the hESC colonies
for alkaline phosphatase and with antibodies specific for
SSEA-4, TRA-1-60, TRA-1-81 or Oct-3/4 confirmed the
pluripotency of these cells.
Synthesis of cDNA from hESCs
The centers (100 to 200 cells) of hESC colonies from feeder-
free cultures (matrigel) were mechanically picked up with a 25
Fig. 1 The setting of the microfluidic device for single hESC mRNA
extraction. A. The system includes a microscope, a computer to control
air pressure with pressure regulators, and a heating stage to heat the
microfluidic chip to desire temperatures. B. A typical microfluidic chip.
C. Merged image of immunofluorescent stained (Oct-3/4) and light
microscope images from a pluripotent hESC colony. The hESC colony
was labeled with mouse a human Oct-3/4 IgG and PE-conjugated
rabbit anti-mouse IgG antibodies. Only cells in the center of the hESC
colony expressed Oct-3/4. The intensity of the labeling indicates the
Oct-3/4 positive cells expressed Oct-3/4 at different levels. The sponta-
neously differentiated cells around the colony do not express Oct-3/4.
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gauge needle. The cells were disassociated into single-cell
suspension with trypsin. After being labeled with a DNA-
selective dye for living cells, Vybrant DyeCycle Green
(Invitrogen, USA), FACS was performed to isolate cells in
the G0/G1 phase based on DNA content. These isolated cells
were pooled to extract total RNA with Trizol LS (Invitrogen,
USA), or loaded into the microfluidic device for processing.
Typically, 150 000 FACS sorted cells were pooled for Trizol
RNA extraction, and 2000 to 5000 cells were used for micro-
fluidic experiments. To compare the efficiency of bench-top
bulk assays to microfluidic assay, the same biochemical reagents
were used for the bulk assay and the microfluidic device.
Single-cell lysis, mRNA capture and RT were performed in
the same microfluidic device to convert mRNA into cDNA.
Dynabeads with oligo (dT)25 (Invitrogen, USA) were used to
capture mRNA. Sensiscript RT kit (Qiagen, USA) was used
for converting captured mRNA to cDNA. The oligo (dT)25
sequence in Dynabeads serves as both mRNA capture
sequence and primer for cDNA synthesis. After oligo (dT)25
beads with attached cDNA were flushed to the collection wells,
the wells were cut off from the chip. Centrifugation was used
to transfer the beads from individual wells into PCR tubes.
These beads with attached cDNA from individual cells were
subjected to realtime qPCR for measurement of the number of
molecules of interrogated mRNA in IQ5 (Bio-Rad, USA).
Microfluidic device and single-cell process
The basic components of a microfluidic processor are shown in
Fig. 2. The processor captures mRNA from 20 single-cells
separately and simultaneously, then converts it into individual
cDNA. The lysis buffer was loaded into the flow channels until
it reached the waste outlets, so as to leave no air bubbles in the
channel. Oligo (dT)25 beads (Invitrogen, USA) were then
loaded and columns were built serially by addressing flow lines
individually with the multiplexer control channels, while
keeping the sieve valve actuated. Once columns were built,
excess beads still present in the flow channels were flushed
with the lysis buffer to the constructed columns. A single-cell
suspension was then loaded. By adjusting cell concentration
and flow rate to obtain optimal distance between two floating
cells, single hESC was captured in individual cell lysis module
(approximately 80% of modules captured only one cell).
Microscopic examination was performed to ensure that only
cDNA from modules that captured one cell will be used for
PCR analysis. Cells were then lysed chemically by mixing cells
with the lysis buffer in the y10 nL ring (Fig. 2 insert 1).
Mixing occurred by executing a peristaltic pump sequence25,26
with control channels. Cell lysates were then pushed via
pneumatic pressure over the affinity columns to captured
mRNA with oligo (dT)25 beads. After washing the columns
with a first strand synthesis buffer, the reverse transcription
(RT) master mix was introduced. Once the RT master mix
filled the flow channels, first strand synthesis was then carried
out by heating the processor to 40 uC on a thermal microscope
stage. The oligo (dT)25 beads served as both primers (oligo
(dT)25 sequences and a solid phase support. The RT reaction
mixture (99 mL) was flown over the columns for 45 min until
the RT reaction was completed at a flow rate of y20 mm s21.
Upon completion of the RT reaction, the waste valves were
closed, and collection valves were opened. The beads were sent
to collection wells by opening the sieve valves and flowing
columns of the processor in a serial manner with a PCR buffer.
The fluid multiplexer was used to push beads in each of the
20 reaction channels individually. Beads were collected by
cutting the collection wells off the device and centrifuging the
beads into PCR tubes.
Standard curves
Human fetal brain cDNA (Invitrogen, USA) and cDNA
generated from poly-A RNA control kit (Affymetrix, USA)
were used as templates to obtain quantitative PCR amplicons.
Quantification of the PCR amplicons was performed by gel
densitometry with DNA ladders (Norgen, Canada). These
amplicons contain the majority of the cDNA sequence of the
respective genes and were used for generating standard curves
for qPCR. The lys standard curve was generated with a known
amount of a 846 bp fragment of the lys cDNA. The primers
for the amplification were: cagtcaacccttaccgcatt (forward) and
acatggacaggaggcatttc (reverse).
Three sets of primers were used to amplify 905 bp, 982 bp
and 890 bp fragments of B2M, Nodal and Fzd4 respectively
Fig. 2 Single-cell mRNA extraction microfluidic device filled with
food dye for illustration. All flow channels are filled with yellow food
dye, multiplexer control channels are filled with red dye, collection and
waste channels are in blue. The inserts show enlargements of four
important areas of the chip. After loading cell suspension from the cell
input inlet, single-cells are captured in cell lysis module (Insert 1)
within the flow channels (blue). The pump valves are green. The
separation valve is black. The lysis buffer is yellow. A captured single
hESC is labeled with a fluorescent dye (green) and shown in Insert 2.
Cell lysis is performed by opening the portion valve and pumping to
mix lysis buffer (yellow) with the captured cell. The resulting cell lysate
is pushed through oligo-dT bead columns for mRNA capture. Oligo-
dT beads are stacked into columns by closing the sieve valve while
loading bead suspension. Insert 3 shows six stacked oligo-dT bead
columns next to the sieve valve. After washing beads with buffers, RT
reaction master mix is flown through the bead columns to synthesize
cDNA from the captured mRNA at 40 uC. After RT reaction, beads
with attached cDNA are pushed to collection wells (Insert 4) by
opening the sieve valve. The beads are recovered by cutting the wells
off the chips and centrifuging a flipped-well in a microcentrifuge tube.
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from human brain cDNA (Invitrogen, USA).The primer sets
were: B2M: ggcattcctgaagctgaca (forward) and ccagattaacca-
caaccatgc (reverse) ; Nodal: cttcctgagccaacaagagg (forward)
and cagactccactgagcccttc (reverse); Fzd4: gggacgtctaaaatcc-
caca (forward) and ggcagtggagatgaaacaca (reverse)
Quantitative PCR
Four sets of multiplex Taqman primers and probes were
designed with Beacon Designer (Premier Biosoft International,
USA). B2M: aattgctatgtgtctgggtttcatcc (forward), gctta-
catgtctcgatcccacttaac (reverse) and acaaagtcacatggttcacacgg-
caggca (probe-FAM); Nodal: catacatccagagtctgctgaaacg
(forward), atcagaggcacccacattcttcc (reverse) and cccacc-
gagtcccttccacttgttgtgcc (probe-Cy5);Fzd4: cgaccccatccgcatctcc
(forward), acattggcacataaacagaacaaagg (reverse) and ccagaa-
cctcggctacaacgtgaccaaga (probe-Hex); Lys: ggccggttttgtgttag-
cag (forward), gcggttcatcatcttccgtataac (reverse) and
ccgaaacctcctccaagattcagcacct (probe-FAM). Multiplex quan-
titative PCR was performed with IQ-5 (bio-rad, USA) and
Quantitect Taqman PCR kit (Qiagen, USA) for B2M, Nodal
and Fzd4. The qPCR of lys was performed independently from
the multiplex qPCR.
Results and discussion
Device efficiency
Single-cell measurement of mRNA is difficult. One difficulty
results from the loss of material during the steps of single-cell
capture, lysis, mRNA isolation and cDNA synthesis. Unlike
the DNA molecule, mRNA is very susceptible to degradation
by widely existing RNase. Therefore, it is essential to carry out
the cDNA first strand synthesis on the same device immedi-
ately after mRNA capture. Another difficulty is the low
mRNA-to-cDNA efficiency, mRNA capture (y40–50%) and
RT reaction (y20%)22,23 in bulk assays.
In order to measure the absolute number of molecules of
mRNA with standard curves, the mRNA-to-cDNA efficiency
of the processor must be obtained. An artificial Poly-A RNA
standard (Affymetrix, USA) was used to compare the input
mRNA copy number to the cDNA copy number which was
measured by qPCR at the end of the processes. This RNA
standard contains known amounts of artificial RNAs with
poly-A tails from 4 B. subtilis genes, lys, phe, thr and dap. The lys
gene was used as RNA standard for calculation of mRNA-to-
cDNA efficiency. A standard curve was generated with a known
amount of lys DNA at 10 fold dilutions. The mRNA capture
and RT reaction were carried out at both conventional micro-
litre level and at nano-litre scale with the microfluidic processor.
In the conventional reaction, a 50 mL RT reaction was
carried out after capturing 4 mL of artificial mRNA (7.3 nM)
with 30 mL oligo (dT)25 beads as instructed by the manufac-
turer. One micro litre of the RT product (corresponding to
2.16 6 108 molecules of lys artificial mRNA) was used for
realtime quantitative PCR (qPCR) detection. Based on the
standard curve, the final detected number of molecules was
2.5¡ 0.5 6 107 molecules (Table 1). The processing efficiency
of conventional micro-litre scale reaction is 12%.
To compare the efficiency of conventional and microfluidic
approaches, the same artificial RNA sample was introduced
into the cell capturing chamber, processed into cDNA and
detected with realtime qPCR. Each of the 20 cell-capture
chambers in the microfluidic device has a volume of 3.4 nL
resulting in 1.84 6 106 molecules of input lys artificial mRNA.
The absolute lys cDNA molecule number detected by
qPCR with the standard curve is 1.0 + 0.3 6 106. The total
processing efficiency was 54% which is approximately 5 times
the efficiency of the conventional approach. A series of 10 fold
dilutions of the artificial RNA were used and they verified that
the processing efficiencies of both approaches do not vary
significantly in different concentrations of the input artificial
RNA. The standard deviations of both bench-top and
microfluidic reactions were also calculated and are similar
(Table 1). The small standard deviation of the 20 reactions in
the same device indicates consistent processing efficiency
among the 20 reaction chambers.
Gene expression of single hESCs
Conventional gene expression studies were carried out with
RNA extracted from cell populations. To investigate whether
the gene expression of cell population is a reasonable sum of
the expressions of individual cells, the expression levels of three
genes were measured by two approaches: with pooled cDNA
from the hESC population and with cDNA from individual
hESCs.
Based on the mRNA-to-cDNA efficiency calculated above,
the numbers of three mRNAs in a single hESC were measured.
Standard curves were constructed with known amounts of full
length B2M, Fzd 4 and Nodal cDNA. The three standard
curves overlap each other, indicating similar qPCR efficiency
for each set of the primers (Fig. 3A). These standard curves
have a range of 2 to 2 6 106 molecules that allow the direct
comparison of the expression levels of these three genes
from their amplification curves (Fig. 3B). The minimal
detectable level is 4 molecules (2/54%) for our microfluidic
processor, and 17 molecules (2/12%) for bulk assays with these
standard curves.
Table 1 Microfluidic device increasing mRNA capture and reverse transcription (RT) efficiency. Known amounts of artificial Lys mRNAs in a
mixture with 3 other poly-A artificial RNAs were processed with traditional microliter scale reaction or with microfluidic device in nanoliter scale.
A standard curve was generated with known amount of lys DNA for the detection of the number of molecules of cDNA (y = 23.5547x + 39.538
R2 = 0.99). The molecule number of lys cDNA was calculated from the standard curve with real-time PCR threshold cycles. Processing efficiencies
were calculated by dividing the measured number of cDNA molecules with the number of input mRNA molecules
Input Lys RNA
(molecule number) Threshold Cycle
Detected cDNA
(molecule number)
Efficiency
(%)
Microlitre Reaction (Bench-top) 2.16 6 108 13.22 ¡ 0.37 (n = 20) 2.6 ¡ 0.6 6 107 12
Nanolitre Reaction (Microfluidic) 1.84 6 106 18.15 ¡ 0.46 (n = 20) 1.0 ¡ 0.3 6 106 54
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The pluripotent hESC colonies are often considered and
treated as a homogenous population. However, our data
indicate that this is not the case. As Fig. 3B shows, the
absolute expression levels (mRNA molecule number) mea-
sured from cDNA equivalents to 1000 cells are not even close
to 1000 fold of the levels measured from a typical single-cell.
With cDNA equivalent to 1000 G1/G0 phase hESC, the
absolute molecule numbers of B2M, Nodal and Fzd4 are
6,034 ¡ 660, 402 ¡ 55 and 69 ¡ 19 respectively. However,
the distributions of the molecule numbers of these 3 genes
are diverse in single hESCs (Fig. 4). Among the 54 interrogated
single hESCs, 14.8%, 37% and 37% of hESC did not express
detectable levels (less than 4 copies) of B2M, Fzd4 and Nodal
respectively. The expression of B2M ranged from 4 to 76
copies, with the majority between 30 and 50 copies. The
expression of Fzd4 and Nodal ranged from 6 to 548 copies, and
22 to 504 copies respectively. All cells expressed at least one of
the 3 genes.
Many gene expression studies, such as microarray or
quantitative PCR, are based on the relative expression level
of genes with normalization to a house keeping gene which
is assumed to have a similar expression in all samples. Our
data show that even the relative expression level of the three
genes are very different between measurements derived from
cDNA of a cell population and separately from individual
cells. In the measurement from population cDNA, the
expression level of Fzd4 is approximately 8 fold lower than
the expression of Nodal after being normalized to B2M.
However, in a representative single hESC, the expression
levels of Nodal and Fzd4 are very similar after normalization
with B2M (Fig. 4).
Conclusions
Microfluidic devices that are designed to manipulate nanolitre
amounts of reagents provide a desirable platform for single-
cell gene expression processing. As our data indicate, capturing
mRNA and converting it to cDNA in a microfluidic device
not only consumes significantly less reagents, but most
importantly increases the efficiency of biochemical reactions.
The microfluidic device described has a mRNA-to-cDNA
efficiency 5 times better than the corresponding bench top
reactions. Previous studies showed a 40–55% mRNA capture
efficiency of oligo (dT)25,
22 and y20% RT efficiency23 in
conventional bench top reactions. The 12% overall efficiency
of our bulk assay is consistent with these previous studies
(55% 6 20%). With our microfluidic device, the mRNA-to-
cDNA processing efficiency is 54% (5 fold better than bulk
assay). This finding indicates a very efficient mRNA-to-cDNA
processing that may be due to the nanolitre scale reaction.
This mRNA-to-cDNA efficiency is similar to the previously
reported efficiency from other microfluidic devices.27
Due to the nanolitre scale nature of the microfluidic device,
the input number of mRNA in conventional reaction and
microfluidic reaction is y100 fold different when same RNA
standard is used. To rule out the possibility of RNA
concentration in processing efficiency, serial 10-fold dilutions
of the RNA standard were used for the same experiments. The
mRNA-to-cDNA efficiencies are not significantly different for
both bench-top and microfluidic reactions. Therefore, the high
mRNA-to-cDNA efficiency is a desirable characteristic of
microfluidic devices. With this 54% processing efficiency, the
microfluidic device described potentially can detect 2 mRNA
copies of interrogated genes.
Fig. 3 Measuring the absolute molecule number of the three genes in a single hESC with multiplex quantitative PCR. A. Standard curves are
generated with known amounts of plasmid DNA containing the full sequence of the genes. The curves cover from 2 to 2 6 106 copies of the
respective genes. With our primer design, all the curves overlap each other, and indicate similar PCR efficiency. B. The multiplex quantitative PCR
amplification curves obtained from cDNA of hESC colonies are plotted with curves obtained from cDNA of a representative hESC. Because the
standard curves of the three genes are very similar, these amplification curves show that the expression ratio of B2M and Nodal is similar in
population cDNA and this single-cell cDNA. However, the expression of Fzd4 and Nodal is very similar in this particular single hESC, but very
different in the hESC population. Unlike this single hESC, some single hESC do not express all three genes. This result suggests the heterogeneity of
hESC and underscores the importance of single-cell analysis.
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In our device, there are 20 individual single-cell processing
reactors for simultaneously processing. The standard deviation
of threshold cycles of the 20 reactors is small (0.37) and similar
to those from conventional reactions (y0.5). These data
indicate that the processing efficiencies among the 20 reactors
are very similar. Similar results are also obtained in multiple
lots of devices. This aspect is critical for comparing results
from individual cells intra- and inter-devices.
With this device, we profiled the expression of three genes in
hESC. Our data indicated that even for FACS-sorted G1/G0
phase hESC, the expression data from population cDNA can
not be used to estimate the gene expression level in individual
cells. Therefore, the population averaging effect distorts the
expression levels of the three genes in bulk assays conducted
with population cDNA from hESC colonies. Because the
population averaging effects are not the same for all three
genes, the relative expression levels are also distorted. The
qPCR with cDNA from 1000 hESC indicates that Nodal
is expressed approximately 8 times more than Fzd4 after
normalization to B2M. However, in individual cells the
expressions of these genes are very diverse. The difference
observed in pooled cDNA may be due to the different number
of cells expressing the respective genes.
It has been reported that gene expression is highly variable
in the single-cell levels.28,29 A speculation is that the high
variability is due to experimental variation. In the present
study, we showed that experimental variation may not be the
main factor. The stochastic gene expression behavior of single-
cells (biological noise) has been reported in various studies of
prokaryote cells.30–34 Biochemical processes such as transcrip-
tion, translation, RNA and protein degradation have been
thought of as the primary contributors. However, hetero-
geneity of the mammalian cell populations may be a factor
related to the observed expression variations in single-cell
analysis of mammalian cells. When gene expression studies
are conducted at the single-cell level, we must recognize that
no two cells are identical. In a particular mammalian cell
population, two cells always are different in cell cycle,
Fig. 4 Expression of B2M, Nodal and Fzd4 in single hESCs. A. A single-hESC expresses both Nodal and Fzd4, but does not express B2M in a
detectable level. B. A single hESC expresses only Nodal. The mRNAs of B2M and Fzd4 are undetectable. C, D and E shows the distribution of
B2M, Fzd4 and Nodal in single hESCs. Among the 54 interrogated single hESCs, 14.8%, 37% and 37% of cells (indicated by black strait pattern) do
not express detectable levels (less than 4 copies) of B2M, Fzd4 and Nodal respectively. The distribution pattern of expressions is narrower for B2M
compared to the other 2 genes. The discontinuous distribution of Nodal and Fzd4 suggest a high heterogeneity of the 54 cells.
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differentiation stages, and environmental stimulation. The
variation of gene expression at the single-cell levels is expected,
and the reason may be due to stochastic expression fluctua-
tion, or due to heterogeneity of the cell populations. In
mammalian cells which are regulated by more complex gene
networks than yeast and bacteria, cell heterogeneity may be
the major contributor of variation of gene expression at single-
cell levels.
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